A Study in Chinese Patients With Acquired Blepharoptosis
Clinical trial NCT06683651 · RECRUITING
Trial details
- NCT number
- NCT06683651
- Sponsor
- Santen Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2026-06-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.